Initial results of KD025-208: A phase 2a open-label clinical trial of KD025 for steroid-dependent chronic graft versus host disease (cGVHD)

Authors
Category Primary study
JournalBiology of Blood and Marrow Transplantation
Year 2018
This article has no abstract
Epistemonikos ID: f66c30354e0bed595763f7edb0e3af25b9a764a0
First added on: Feb 09, 2025